ProMIS Neurosciences Inc. (PMN)

ProMIS Neurosciences Inc. (PMN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $74.3M; returns 1 day -7.1%, 1 week +2.3%, 1 year -22.4%.

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company based in Toronto, Canada, and Cambridge, Massachusetts, focused on discovering and developing antibody therapies and therapeutic vaccines for neurodegenerative diseases, particularly those involving misfolded proteins.

Groups PMN belongs to

• Recent Reverse Splits
• Canada Companies
• Biotechnology
• Clinical Stage Biotech
• Neuroscience
• Alzheimer's Disease
• Antibody Therapeutics
• Monoclonal Antibodies
• Clinical Stage
• CNS Disorders
• Neurological Disorders
• Life Sciences
• Drug Discovery
• Healthcare
• Biopharmaceutical

PMN financial model: income statement, cash flow and balance sheet